ABOUT

We strive to develop safe & effective cancer therapies

We are a dedicated and multidisciplinary team of scientists, researchers, and professionals who collaborate to drive innovation, push the boundaries of scientific discovery, and contribute to advancements in the field of cancer immunotherapy.

OUR MISSION

Precision immunotherapy for
hard-to-treat cancers

Our mission is to lead the frontier of biomedical innovation by dedicating ourselves to the development of groundbreaking immunotherapies. We are passionately committed to the pursuit of solutions that go beyond conventional boundaries, aiming to develop and advance treatments targeting cancer antigens that were once considered impervious to therapeutic intervention.

We believe in the possibility of transforming what was once thought impossible into a tangible reality, and through our unwavering commitment to this mission, we strive to make a lasting impact on the lives of those affected by cancer.

OUR VALUES

Our driving force behind our mission to revolutionize cancer immunotherapy

With an unwavering commitment to innovation, ethical excellence, and a profound dedication to patients our values are the guiding principles propelling our mission to redefine the landscape of immunotherapy and positively impact lives worldwide.

Care

Is our ambition to improve the life of cancer patients.

Team-thinking

It is the key to delivering innovative solutions.

Personal growth

We pursue growth and learning.

Excellence

We strive to be the best in what we do.

Integrity

We work on the things that matter.

Meet
our team

“To realize cures for cancer patients, we need to transition from a one-size-fits all approach to one which is tailored to a patient’s tumor. By exploiting the capabilities of AI and synthetic biology, our dedicated teams are cracking the code of how we can identify tumor specific targets and design therapeutics that are both effective and safe. I feel fortunate to work with these great people and look forward to the progress we’ll make together.”

CEO

Jan-Jaap Verhoef (PhD)

Driven to make an impact on the life of patients. With 15 years of experience in starting companies, Jan-Jaap makes sure the team is focused and fueled with great coffee.

"Within the realm of drug discovery, AI emerges as the guiding force, paving the way for revolutionary immunotherapies, offering hope to countless lives. I inspire to leverage my expertise in biology, bioinformatics, AI, engineering and management to effectively lead the team and bring this vision to life."

Head of Bioinformatics

Simona Aufiero (PhD)

A highly experienced bioinformatic engineer, with a 15-year background in designing innovative bioinformatic solutions for tackling complex biological challenges.

“I've always been fascinated by the intrinsic ability of our immune systems to recognize and fight cancer. However, comprehending the intricacies of how immune systems recognize cancer is highly complex. I'm thrilled to be part of a team utilizing artificial intelligence to address this challenge. It is our hope that this integrated approach will expedite the discovery of immunotherapies, ultimately saving patient lives.”

Senior Scientist

Joanna Turley (PhD)

Immunologist with over 7 years of experience in Pre-Clinical Research & Discovery

"In the quest for a cancer cure, the synergy of bioinformatics and wet lab experimentation becomes the catalyst, and I am driven by an unwavering commitment to seamlessly integrate expertise in biology, bioinformatics, and engineering. This convergence holds the potential to unlock groundbreaking discoveries and revolutionize cancer treatment, fueling my passion to contribute significantly to this transformative field."

Bioinformatician

Roberto Fornelino

An experienced bioinformatician in molecular modelling techniques and developing sophisticated bioinformatics pipeline for precision immunotherapy.

“AI technologies offer revolutionary approaches to improve immunotherapies, and I'm thrilled to contribute to the cause of Imuno, translating AI advancements into practical solutions that can benefit patients.”

Senior Scientist

Michail Mamantopoulos (PhD)

An experienced immunologist with expertise in molecular biology techniques for DNA library generation, cell assay development and high-throughput screening.

“I have always been interested in the field of immunology. Now it is being combined with the AI to achieve immunotherapies which were not possible before. As an intern I hope I can eventually say that I made a meaningful contribution to the wellbeing of patients. I hope I will be able to learn useful skills at Imuno so I can become a better bioinformatician.”

Junior bioinformatician

Tim van der Lee

A bioinformatics intern from the University of applied sciences Leiden with a passion for immunology and immunotherapy.

“In the ever-advancing field of healthcare, the collaboration of computer science and biology opens the way for real-world breakthroughs in immunotherapy and personalized medicine. My dedication is to this powerful synergy, aiming to translate complex bioinformatics into tangible benefits for patient care. It's my firm belief that through diligent research and innovative application of technology, we can develop personalized treatments that are not just a vision, but a reality — offering each patient care that is as unique as their own genetic makeup.”

Junior bioinformatician

Nick Bounatsos

A passionate bioinformatician, with a unique blend of expertise in computer science and a fervent enthusiasm for biology.

"The intricate interactions between cancer cells and the immune system are fascinating, yet many aspects remain unclear. I'm enthusiastic about being part of a team dedicated to overcoming these challenges by developing effective immunotherapies. Leveraging AI data to guide targeted wet lab experiments is thrilling and optimizes our approach. By combining our knowledge and expertise, we aspire to bring hope to numerous cancer patients."

Junior Scientist

Aurelia Ciarelli

A dedicated science intern, driven by a passion for immunology in cancer development and striving to make meaningful contributions to the healthcare innovation sector.

Our
location

Situated in the vibrant city of Leiden, our company strategically leverages its location at the crossroads of innovation, tapping into the dynamic ecosystem of the city’s renowned life sciences community.